Blood Processing and Storage Equipment Market Size - By Product (Device (Plasma Freezer, Hematocrit Centrifuge, Warmer) Consumable (Blood Lancet, Filter, Administration Set)), End-use

Description

List of Tables

Blood Processing and Storage Equipment Market size is poised to expand at 7.1% CAGR from 2023-2032 owing to the increasing prevalence of blood disorders globally. Conditions, such as anemia, hemophilia, and leukemia are necessitating advanced blood processing and storage solutions for diagnosis, treatment, and therapeutic interventions. The rising incidence of these disorders coupled with the growing aging population is further driving the demand for efficient and reliable equipment in healthcare facilities.

With the advancing medical research activities, industry participants are developing new therapies and treatments to address the escalating requirement for sophisticated blood processing and storage technologies, augmenting the industry outlook. For instance, Terumo Blood and Cell Technologies, in August 2023, received the U.S. FDA approval for the Reveos Automated Whole Blood Processing System to help process blood into platelets and various components in a single centrifugation cycle.

The blood processing and storage equipment market is segmented into product, end-use, and region.

Based on product, the market share from the consumables segment, comprising blood lancet, filter, and administration, is estimated to record 7.3% CAGR from 2023-2032. The rapidly aging population, the rising awareness about blood transfusions and higher advances in medical procedures is surging the demand for efficient blood processing and storage. Additionally, the rising innovations in materials and technologies to ensure enhanced safety and efficacy in blood management are likely to propel the segment growth.

In terms of end-use, the blood processing and storage equipment industry from the hospitals and clinics segment generated substantial revenue in 2022 and is estimated to witness 6.9% growth rate through 2032. Hospitals and clinics rely heavily on efficient blood management systems to ensure patient safety and streamline the medical procedures. Furthermore, the increasing demand for blood-related treatments, surgeries, and emergency care in healthcare facilities is promoting the adoption of advanced processing and storage equipment.

Asia Pacific blood processing and storage equipment industry is set to exhibit a 7.8% CAGR through 2032 owing to the ongoing healthcare infrastructure development, rising awareness about blood safety, and the growing population. Moreover, advancements in medical technology and the rising need for blood-related treatments are fueling the adoption of sophisticated processing and storage equipment. Furthermore, several governments across the Asia Pacific are investing in healthcare infrastructure for enhancing the capabilities of blood banks and medical facilities attributed to the rising focus on public health, further boosting the regional industry expansion.

Product Code: 4075

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global blood processing and storage equipment market 360 degree synopsis, 2018 - 2032
2.2 Regional trends
2.3 Product trends
2.4 End-use trends

Chapter 3 Blood Processing and Storage Equipment Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Increasing prevalence of chronic diseases
  - 3.5.1.2 Technological advancement in blood processing and storage equipment
  - 3.5.1.3 Surge in the number of road traffic accidents
  - 3.5.1.4 Growing awareness regarding blood donation
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 High cost associated with blood processing devices
  - 3.5.2.2 Stringent regulatory scenario
3.6 Growth potential analysis
- 3.6.1 By product
- 3.6.2 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Becton, Dickinson and Company
- 4.1.2 Bio-Rad Laboratories, Inc.
- 4.1.3 Grifols, S.A.
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022

Chapter 5 Blood Processing and Storage Equipment Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1 Key trends, by product
5.2 Devices
- 5.2.1 Plasma freezers
- 5.2.2 Blood bank refrigerators
- 5.2.3 Lab refrigerators
- 5.2.4 Lab freezers
- 5.2.5 Ultralow temperature freezers
- 5.2.6 Shock freezers
- 5.2.7 Grouping analyzers
- 5.2.8 Warmers
- 5.2.9 Hematocrit centrifuges
- 5.2.10 Cell processors
5.3 Consumables
- 5.3.1 Blood administration sets
- 5.3.2 Blood bags
- 5.3.3 Blood collection needles
- 5.3.4 Blood collection tube
- 5.3.5 Blood filters
- 5.3.6 Blood lancets
- 5.3.7 Blood grouping reagents
- 5.3.8 Blood coagulation reagents
- 5.3.9 Hematology reagents
- 5.3.10 Other consumables

Chapter 6 Blood Processing and Storage Equipment Market Size and Forecast, By End-use, 2018-2032 (USD Million)

6.1 Key trends, by end-use
6.2 Blood banks
6.3 Hospitals & clinics
6.4 Diagnostic laboratories
6.5 Other end-users

Chapter 7 Blood Processing and Storage Equipment Market Size and Forecast, By Region, 2018-2032 (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East & Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East & Africa

Chapter 8 Company Profiles

8.1 Beckman Coulter, Inc.
8.2 Thermogenesis Holdings, Inc.
8.3 Maco Pharma International GmbH
8.4 Immucor, Inc.
8.5 Becton, Dickinson and Company
8.6 Bio-Rad Laboratories, Inc.
8.7 Grifols, S.A.
8.8 Abbott Laboratories
8.9 Global Scientific Company
8.10 Sigma Laborzentrifugen GmbH
8.11 Terumo BCT, Inc.
8.12 Poly Medicure Ltd
8.13 Thermo Fisher Scientific, Inc.
8.14 Biomerieux
8.15 F. Hoffmann-La Roche Ltd